Enterome Raises €32 Million ($38.5 Million) in a Series D Financing

Proceeds will be used to progress lead development programs - EB8018 for IBD and EO2315 for cancer

Secures €40 million loan facility ($48 million) from the European Investment Bank

PARIS and CAMBRIDGE, Massachusetts, January 4, 2018 -- (Healthcare Sa... Biopharmaceuticals, Venture Capital Enterome

Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news